Loading term…
Recommendations in a periodic report for updating product labeling or risk management measures based on safety findings.
Based on PSUR findings, proposed actions include: adding 'hepatotoxicity' to Section 4.4 Warnings, updating Section 4.8 with incidence data, and recommending liver function monitoring.
ICH E2C(R2)
Not including specific proposed text for labeling changes, or proposing changes without adequate supporting evidence.
How do you determine when findings warrant labeling changes? Who approves proposed actions?